The expression levels of DLX6, as revealed by immunohistochemical staining of NPC samples and normal nasopharyngeal specimens, confirmed that DLX6 expression was significantly elevated not only in NPC compared to normal nasopharyngeal specimens but also in NPC metastasis. The gene discussed is DLX6; the disease is nasopharyngeal carcinoma.